{
    "code": "52026130",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026130",
    "time": "2018-03-16 03:14:03",
    "許可證字號": "衛部藥輸字第026130號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/08\/06",
    "發證日期": "102\/08\/06",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202613002",
    "中文品名": "速避凝多次劑量瓶注射液",
    "英文品名": "Fraxiparine Multidose Vials, Solution for Injection",
    "適應症": "血栓性栓塞及其預防、抗凝血。與ASPIRIN併用治療急性非穩定性心絞痛和非Q波型心肌梗塞。",
    "劑型": "270注射劑",
    "包裝": "每5毫升、15毫升小瓶 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "NADROPARINECALCIUM"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "6401022326  安沛國際有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F130192000  GLAXO OPERATIONS UK LIMITED",
        "製造廠廠址": "HARMIRE ROAD, BARNARD CASTLE, COUNTY DURHAM, UNITED KINGDOM, DL12 8DT U.K.",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012401510",
            "成分名稱": "NADROPARINE CALCIUM",
            "含量描述": "",
            "含量": "9500.0000000000",
            "單位": "IU-AXA"
        }
    ],
    "仿單外盒": [
        {
            "title": "020261300001-102-09-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026130&Seq=001&Type=9"
        },
        {
            "title": "020261300002-102-09-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026130&Seq=002&Type=8"
        }
    ]
}